Corbus Pharmaceuticals Holdings Inc

General ticker "CRBP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $189.5M

Corbus Pharmaceuticals Holdings Inc follows the US Stock Market performance with the rate: 8.6%.

Estimated limits based on current volatility of 2.5%: low 13.10$, high 13.78$

Factors to consider:

  • Current price 42.3% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.41$, 9.14$]
  • 2024-12-30 to 2025-12-30 estimated range: [2.54$, 6.98$]

Financial Metrics affecting the CRBP estimates:

  • Negative: Non-GAAP EPS, $ of -10.37 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -60.10 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of -100 <= -1.03

Similar symbols

Short-term CRBP quotes

Long-term CRBP plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.88MM $0.00MM $0.00MM
Operating Expenses $56.87MM $39.84MM $45.08MM
Operating Income $-55.99MM $-39.84MM $-45.08MM
Non-Operating Income $10.35MM $-2.51MM $0.47MM
Interest Expense $1.83MM $2.13MM $2.92MM
R&D Expense $36.45MM $16.14MM $31.17MM
Income(Loss) $-45.64MM $-42.35MM $-44.60MM
Profit(Loss) $-45.64MM $-42.35MM $-44.60MM
Stockholders Equity $69.11MM $32.99MM $-6.90MM
Assets $107.73MM $66.31MM $28.27MM
Operating Cash Flow $-48.18MM $-37.54MM $-36.10MM
Capital expenditure $0.05MM $0.01MM $0.00MM
Investing Cash Flow $-73.42MM $30.07MM $35.64MM
Financing Cash Flow $60.82MM $-0.53MM $-2.82MM
Earnings Per Share* $-11.11 $-13.39 $-10.31

* EPS are Split Adjusted, recent splits may be reflected with a delay.